RNA-Targeted Small Molecules Market Size, Share & Trends Analysis Report By Product & Service (mRNA translation regulation, Indirect RNA targeting-epitranscriptomics, RNA Splicing Modification, Direct RNA Targeting), By Application (Drug discovery, Oncology research, Disease identification), By End-User, By Region, And By Segment Forecasts, 2024-2031

Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global RNA-Targeted Small Molecules Market Snapshot Chapter 4. Global RNA-Targeted Small Molecules Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Porter's Five Forces Analysis 4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031 4.8. Global RNA-Targeted Small Molecules Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031 4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023) 4.10. Use/impact of AI on RNA-Targeted Small Molecules Industry Trends Chapter 5. RNA-Targeted Small Molecules Market Segmentation 1: By Product & Service, Estimates & Trend Analysis 5.1. Market Share by Product & Service, 2023 & 2031 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product & Service: 5.2.1. mRNA Translation Regulation 5.2.2. Indirect RNA Targeting-Epitranscriptomics 5.2.3. RNA Splicing Modification 5.2.4. Direct RNA Targeting Chapter 6. RNA-Targeted Small Molecules Market Segmentation 2: By Application, Estimates & Trend Analysis 6.1. Market Share by Application, 2023 & 2031 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Applications: 6.2.1. Drug Discovery 6.2.2. Oncology Research 6.2.3. Disease Identificatio Chapter 7. RNA-Targeted Small Molecules Market Segmentation 3: By End user, Estimates & Trend Analysis 7.1. Market Share by End user, 2023 & 2031 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End users: 7.2.1. Hospitals 7.2.2. Research Laboratories 7.2.3. Contract Research Organizations 7.2.4. Pharmaceutical and Biotechnology Companies Chapter 8. RNA-Targeted Small Molecules Market Segmentation 6: Regional Estimates & Trend Analysis 8.1. Global RNA-Targeted Small Molecules Market, Regional Snapshot 2023 & 2031 8.2. North America 8.2.1. North America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 8.2.1.1. US 8.2.1.2. Canada 8.2.2. North America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031 8.2.3. North America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031 8.2.4. North America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031 8.3. Europe 8.3.1. Europe RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 8.3.1.1. Germany 8.3.1.2. U.K. 8.3.1.3. France 8.3.1.4. Italy 8.3.1.5. Spain 8.3.1.6. Rest of Europe 8.3.2. Europe RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031 8.3.3. Europe RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031 8.3.4. Europe RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031 8.4. Asia Pacific 8.4.1. Asia Pacific RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 8.4.1.1. India 8.4.1.2. China 8.4.1.3. Japan 8.4.1.4. Australia 8.4.1.5. South Korea 8.4.1.6. Hong Kong 8.4.1.7. Southeast Asia 8.4.1.8. Rest of Asia Pacific 8.4.2. Asia Pacific RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031 8.4.3. Asia Pacific RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031 8.4.4. Asia Pacific RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts By End user, 2024-2031 8.5. Latin America 8.5.1. Latin America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031 8.5.1.1. Brazil 8.5.1.2. Mexico 8.5.1.3. Rest of Latin America 8.5.2. Latin America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031 8.5.3. Latin America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031 8.5.4. Latin America RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031 8.6. Middle East & Africa 8.6.1. Middle East & Africa RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031 8.6.1.1. GCC Countries 8.6.1.2. Israel 8.6.1.3. South Africa 8.6.1.4. Rest of Middle East and Africa 8.6.2. Middle East & Africa RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by Product & Service, 2024-2031 8.6.3. Middle East & Africa RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by application, 2024-2031 8.6.4. Middle East & Africa RNA-Targeted Small Molecules Market Revenue (US$ Million) Estimates and Forecasts by End user, 2024-2031 Chapter 9. Competitive Landscape 9.1. Major Mergers and Acquisitions/Strategic Alliances 9.2. Company Profiles 9.2.1. AstraZeneca 9.2.1.1. Business Overview 9.2.1.2. Key Product/Service Offerings 9.2.1.3. Financial Performance 9.2.1.4. Geographical Presence 9.2.1.5. Recent Developments with Business Strategy 9.2.2. Pfizer 9.2.3. Bentham Scienc 9.2.4. PharmTech 9.2.5. Nymirum Inc. 9.2.6. Accent Therapeutics 9.2.7. Anima Biotech Inc. 9.2.8. Expansion Therapeutics 9.2.9. Bristol-Myers Squibb 9.2.10. Novartis 9.2.11. Other Market Players